| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporotic Fractures | 9 | 2020 | 401 | 2.030 |
Why?
|
| Spinal Fractures | 8 | 2020 | 696 | 1.700 |
Why?
|
| Gait | 11 | 2022 | 793 | 1.530 |
Why?
|
| Movement | 8 | 2019 | 1471 | 1.370 |
Why?
|
| Fractures, Compression | 4 | 2019 | 133 | 1.280 |
Why?
|
| Geriatric Assessment | 5 | 2014 | 1372 | 1.100 |
Why?
|
| Scoliosis | 8 | 2023 | 725 | 0.950 |
Why?
|
| Spinal Fusion | 10 | 2020 | 1241 | 0.940 |
Why?
|
| Muscle Strength | 4 | 2023 | 592 | 0.880 |
Why?
|
| Teriparatide | 4 | 2022 | 225 | 0.870 |
Why?
|
| Thoracic Vertebrae | 9 | 2022 | 608 | 0.840 |
Why?
|
| Posture | 4 | 2014 | 958 | 0.830 |
Why?
|
| Ankle | 2 | 2023 | 327 | 0.810 |
Why?
|
| Alendronate | 2 | 2020 | 171 | 0.710 |
Why?
|
| Spondylitis | 2 | 2021 | 22 | 0.650 |
Why?
|
| Skin Pigmentation | 1 | 2019 | 282 | 0.600 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2017 | 85 | 0.600 |
Why?
|
| Bone Density Conservation Agents | 3 | 2022 | 772 | 0.590 |
Why?
|
| Isometric Contraction | 3 | 2015 | 143 | 0.590 |
Why?
|
| Fracture Healing | 2 | 2017 | 427 | 0.580 |
Why?
|
| Bone Malalignment | 1 | 2016 | 38 | 0.560 |
Why?
|
| Lumbar Vertebrae | 9 | 2022 | 1848 | 0.560 |
Why?
|
| Palladium | 2 | 2014 | 65 | 0.560 |
Why?
|
| Dogs | 5 | 2011 | 3912 | 0.560 |
Why?
|
| Conjunctivitis | 1 | 2017 | 158 | 0.540 |
Why?
|
| Doxycycline | 1 | 2017 | 326 | 0.530 |
Why?
|
| Dura Mater | 1 | 2017 | 291 | 0.530 |
Why?
|
| Kyphosis | 4 | 2021 | 237 | 0.510 |
Why?
|
| Absorbable Implants | 1 | 2017 | 342 | 0.510 |
Why?
|
| Lysergic Acid | 2 | 2011 | 2 | 0.510 |
Why?
|
| Axons | 8 | 2010 | 1685 | 0.500 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2022 | 1458 | 0.470 |
Why?
|
| Cervical Vertebrae | 3 | 2021 | 976 | 0.460 |
Why?
|
| Upper Extremity | 2 | 2019 | 648 | 0.450 |
Why?
|
| Sex Characteristics | 1 | 2023 | 2585 | 0.450 |
Why?
|
| Gonorrhea | 1 | 2017 | 335 | 0.440 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 3 | 2011 | 648 | 0.430 |
Why?
|
| Occipital Bone | 1 | 2012 | 54 | 0.420 |
Why?
|
| Atlanto-Occipital Joint | 1 | 2012 | 33 | 0.420 |
Why?
|
| Ethylene Oxide | 1 | 2011 | 27 | 0.400 |
Why?
|
| Low Back Pain | 1 | 2020 | 956 | 0.400 |
Why?
|
| Pyramidal Tracts | 2 | 2010 | 256 | 0.400 |
Why?
|
| Dietary Fats | 1 | 2019 | 2016 | 0.390 |
Why?
|
| Brain Injuries | 9 | 2010 | 2029 | 0.390 |
Why?
|
| Contingent Negative Variation | 1 | 2010 | 34 | 0.380 |
Why?
|
| Thorax | 1 | 2014 | 547 | 0.380 |
Why?
|
| Mycoses | 1 | 2013 | 376 | 0.350 |
Why?
|
| Activities of Daily Living | 3 | 2014 | 2419 | 0.340 |
Why?
|
| Muscle, Skeletal | 5 | 2023 | 4925 | 0.320 |
Why?
|
| Indoles | 2 | 2014 | 1839 | 0.310 |
Why?
|
| H-Reflex | 2 | 2006 | 26 | 0.310 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2010 | 231 | 0.310 |
Why?
|
| Frail Elderly | 1 | 2012 | 693 | 0.310 |
Why?
|
| Japan | 8 | 2020 | 1360 | 0.300 |
Why?
|
| Sodium Channels | 3 | 2009 | 349 | 0.300 |
Why?
|
| Organometallic Compounds | 1 | 2011 | 665 | 0.300 |
Why?
|
| Spine | 4 | 2022 | 1144 | 0.300 |
Why?
|
| Osteoporosis | 3 | 2022 | 1579 | 0.290 |
Why?
|
| Zinc | 1 | 2011 | 684 | 0.290 |
Why?
|
| Ganglia, Spinal | 3 | 2006 | 519 | 0.290 |
Why?
|
| Neutropenia | 2 | 2011 | 895 | 0.280 |
Why?
|
| Arthroscopy | 1 | 2013 | 926 | 0.280 |
Why?
|
| Walking | 2 | 2014 | 1180 | 0.280 |
Why?
|
| Accidental Falls | 1 | 2014 | 1062 | 0.280 |
Why?
|
| Tissue Survival | 1 | 2006 | 118 | 0.270 |
Why?
|
| Male | 59 | 2023 | 350115 | 0.270 |
Why?
|
| Muscular Diseases | 1 | 2010 | 555 | 0.260 |
Why?
|
| Aged, 80 and over | 20 | 2022 | 57776 | 0.260 |
Why?
|
| Clusterin | 1 | 2005 | 72 | 0.260 |
Why?
|
| Aged | 34 | 2023 | 163288 | 0.260 |
Why?
|
| Cyclophosphamide | 1 | 2011 | 2242 | 0.260 |
Why?
|
| Decompression, Surgical | 3 | 2020 | 594 | 0.260 |
Why?
|
| Psychomotor Performance | 3 | 2010 | 1901 | 0.250 |
Why?
|
| Time and Motion Studies | 2 | 2022 | 149 | 0.250 |
Why?
|
| Spinal Stenosis | 2 | 2018 | 255 | 0.250 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2004 | 27 | 0.250 |
Why?
|
| Tetrodotoxin | 2 | 2009 | 259 | 0.240 |
Why?
|
| Trauma, Nervous System | 1 | 2004 | 36 | 0.240 |
Why?
|
| Knee Joint | 4 | 2018 | 1680 | 0.240 |
Why?
|
| Physical Therapy Modalities | 4 | 2019 | 550 | 0.230 |
Why?
|
| Female | 56 | 2023 | 380193 | 0.230 |
Why?
|
| Cell Transplantation | 1 | 2006 | 477 | 0.230 |
Why?
|
| Interferons | 1 | 2007 | 706 | 0.230 |
Why?
|
| Arm | 1 | 2006 | 589 | 0.220 |
Why?
|
| Motor Cortex | 1 | 2010 | 986 | 0.220 |
Why?
|
| Apolipoproteins E | 2 | 2005 | 1438 | 0.210 |
Why?
|
| Catalysis | 3 | 2014 | 762 | 0.210 |
Why?
|
| Discitis | 1 | 2022 | 40 | 0.210 |
Why?
|
| Ligamentum Flavum | 1 | 2022 | 17 | 0.210 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2022 | 19 | 0.210 |
Why?
|
| Range of Motion, Articular | 4 | 2019 | 1578 | 0.200 |
Why?
|
| Hepatitis C, Chronic | 2 | 2007 | 1031 | 0.200 |
Why?
|
| Ankle Joint | 2 | 2023 | 411 | 0.200 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2021 | 75 | 0.200 |
Why?
|
| Diet | 1 | 2019 | 7937 | 0.200 |
Why?
|
| Regeneration | 1 | 2010 | 1485 | 0.190 |
Why?
|
| Middle Aged | 31 | 2023 | 213390 | 0.190 |
Why?
|
| Peptide Hydrolases | 1 | 2004 | 634 | 0.190 |
Why?
|
| Sarcoma | 2 | 2023 | 1897 | 0.190 |
Why?
|
| Postural Balance | 2 | 2022 | 620 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7182 | 0.180 |
Why?
|
| Postoperative Period | 2 | 2022 | 1842 | 0.180 |
Why?
|
| Liposarcoma | 1 | 2023 | 333 | 0.180 |
Why?
|
| Humans | 60 | 2023 | 744366 | 0.180 |
Why?
|
| Xanthophylls | 1 | 2019 | 96 | 0.180 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2015 | 555 | 0.170 |
Why?
|
| Vertebroplasty | 1 | 2020 | 77 | 0.170 |
Why?
|
| Mobility Limitation | 2 | 2014 | 409 | 0.170 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 239 | 0.170 |
Why?
|
| Rats | 15 | 2015 | 24252 | 0.170 |
Why?
|
| Biological Availability | 1 | 2019 | 397 | 0.170 |
Why?
|
| Up-Regulation | 2 | 2005 | 4222 | 0.170 |
Why?
|
| Tissue Engineering | 2 | 2006 | 1880 | 0.160 |
Why?
|
| Electromyography | 5 | 2015 | 1379 | 0.160 |
Why?
|
| Amyloid beta-Peptides | 4 | 2005 | 3587 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2010 | 8300 | 0.160 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2003 | 1121 | 0.160 |
Why?
|
| Spinal Cord Injuries | 1 | 2006 | 931 | 0.150 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2007 | 1164 | 0.150 |
Why?
|
| Lower Extremity | 2 | 2016 | 1158 | 0.150 |
Why?
|
| Prednisolone | 1 | 2018 | 334 | 0.150 |
Why?
|
| Blood Loss, Surgical | 1 | 2021 | 662 | 0.150 |
Why?
|
| Cyclization | 2 | 2014 | 65 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 2184 | 0.140 |
Why?
|
| Actinobacillus pleuropneumoniae | 1 | 2016 | 8 | 0.140 |
Why?
|
| Postoperative Complications | 5 | 2019 | 15297 | 0.140 |
Why?
|
| Retrospective Studies | 20 | 2023 | 77460 | 0.140 |
Why?
|
| Zygapophyseal Joint | 1 | 2018 | 129 | 0.140 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 12262 | 0.140 |
Why?
|
| Spondylolisthesis | 1 | 2018 | 163 | 0.140 |
Why?
|
| Ceftriaxone | 1 | 2017 | 168 | 0.140 |
Why?
|
| Osteosarcoma | 1 | 2022 | 881 | 0.140 |
Why?
|
| Carotenoids | 1 | 2019 | 624 | 0.140 |
Why?
|
| Hemolysin Proteins | 1 | 2016 | 113 | 0.140 |
Why?
|
| Apoprotein(a) | 1 | 2015 | 18 | 0.140 |
Why?
|
| Connective Tissue Diseases | 1 | 2018 | 264 | 0.130 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2015 | 64 | 0.130 |
Why?
|
| Diphosphonates | 1 | 2020 | 623 | 0.130 |
Why?
|
| Swine | 5 | 2017 | 5918 | 0.130 |
Why?
|
| Malus | 1 | 2015 | 48 | 0.130 |
Why?
|
| Electroencephalography | 1 | 2010 | 6151 | 0.130 |
Why?
|
| Sphingosine | 1 | 2017 | 307 | 0.130 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 154 | 0.130 |
Why?
|
| Aging | 1 | 2014 | 8664 | 0.130 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 5709 | 0.120 |
Why?
|
| Spinal Neoplasms | 1 | 2022 | 760 | 0.120 |
Why?
|
| Wound Infection | 1 | 2017 | 242 | 0.120 |
Why?
|
| Kyphoplasty | 1 | 2015 | 44 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 437 | 0.120 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2017 | 238 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2007 | 2987 | 0.120 |
Why?
|
| Parkinson Disease | 3 | 2019 | 2775 | 0.120 |
Why?
|
| Animals | 29 | 2022 | 168768 | 0.120 |
Why?
|
| Hand | 1 | 2019 | 884 | 0.120 |
Why?
|
| Eimeria | 1 | 2013 | 2 | 0.120 |
Why?
|
| Coccidiostats | 1 | 2013 | 4 | 0.120 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 2029 | 0.120 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 1062 | 0.120 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 18034 | 0.120 |
Why?
|
| Coccidiosis | 1 | 2013 | 13 | 0.120 |
Why?
|
| Poultry Diseases | 1 | 2013 | 25 | 0.120 |
Why?
|
| Spiro Compounds | 1 | 2014 | 76 | 0.120 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.120 |
Why?
|
| Stereoisomerism | 2 | 2011 | 624 | 0.110 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2013 | 66 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 1178 | 0.110 |
Why?
|
| Swine, Miniature | 1 | 2015 | 961 | 0.110 |
Why?
|
| Stress, Mechanical | 4 | 2010 | 1686 | 0.110 |
Why?
|
| Physical Endurance | 1 | 2015 | 370 | 0.110 |
Why?
|
| Erysipelas | 1 | 2012 | 2 | 0.110 |
Why?
|
| Erysipelothrix | 1 | 2012 | 4 | 0.110 |
Why?
|
| Nitrogen | 1 | 2014 | 344 | 0.110 |
Why?
|
| Neurons | 6 | 2010 | 9340 | 0.110 |
Why?
|
| Blotting, Western | 5 | 2009 | 5181 | 0.100 |
Why?
|
| Reference Values | 1 | 2019 | 4982 | 0.100 |
Why?
|
| Exercise Therapy | 1 | 2019 | 904 | 0.100 |
Why?
|
| Adult | 16 | 2023 | 214052 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 1363 | 0.100 |
Why?
|
| Swine Diseases | 1 | 2012 | 73 | 0.100 |
Why?
|
| Device Removal | 1 | 2017 | 656 | 0.100 |
Why?
|
| In Situ Hybridization | 3 | 2005 | 1950 | 0.100 |
Why?
|
| Leukocyte Count | 3 | 2011 | 1588 | 0.100 |
Why?
|
| Ergot Alkaloids | 1 | 2011 | 12 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2023 | 25039 | 0.100 |
Why?
|
| Treatment Outcome | 11 | 2023 | 63107 | 0.100 |
Why?
|
| Spondylosis | 1 | 2012 | 81 | 0.100 |
Why?
|
| Chickens | 1 | 2013 | 865 | 0.100 |
Why?
|
| Ergolines | 1 | 2011 | 61 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 1877 | 0.100 |
Why?
|
| Internal Fixators | 1 | 2012 | 188 | 0.100 |
Why?
|
| Laminectomy | 1 | 2012 | 234 | 0.100 |
Why?
|
| Hepatitis B, Chronic | 1 | 2015 | 393 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1549 | 0.090 |
Why?
|
| Evoked Potentials, Motor | 2 | 2010 | 454 | 0.090 |
Why?
|
| Immunohistochemistry | 6 | 2009 | 11366 | 0.090 |
Why?
|
| Advance Care Planning | 1 | 2018 | 662 | 0.090 |
Why?
|
| Fingers | 2 | 2010 | 513 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2011 | 562 | 0.090 |
Why?
|
| Cerebral Palsy | 1 | 2014 | 459 | 0.090 |
Why?
|
| Channelopathies | 1 | 2009 | 32 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2022 | 2530 | 0.090 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 1035 | 0.090 |
Why?
|
| Adolescent | 13 | 2023 | 85779 | 0.090 |
Why?
|
| Cell Culture Techniques | 3 | 2008 | 1678 | 0.090 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 760 | 0.080 |
Why?
|
| Bone Plates | 1 | 2012 | 468 | 0.080 |
Why?
|
| Dominance, Cerebral | 1 | 2010 | 635 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1622 | 0.080 |
Why?
|
| Bone Screws | 1 | 2012 | 520 | 0.080 |
Why?
|
| Rabbits | 3 | 2016 | 4894 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 1222 | 0.080 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 1122 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 4042 | 0.080 |
Why?
|
| Sodium Channel Blockers | 2 | 2009 | 176 | 0.080 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 2278 | 0.080 |
Why?
|
| Dendrites | 1 | 2010 | 485 | 0.070 |
Why?
|
| Risk Factors | 6 | 2021 | 72296 | 0.070 |
Why?
|
| Escherichia coli | 2 | 2014 | 4217 | 0.070 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 347 | 0.070 |
Why?
|
| Pain Measurement | 4 | 2019 | 3420 | 0.070 |
Why?
|
| Reaction Time | 2 | 2010 | 2098 | 0.070 |
Why?
|
| Young Adult | 7 | 2021 | 56429 | 0.070 |
Why?
|
| SEER Program | 2 | 2022 | 1507 | 0.070 |
Why?
|
| Radiography | 4 | 2018 | 7023 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2010 | 1892 | 0.070 |
Why?
|
| Time Factors | 6 | 2021 | 40075 | 0.070 |
Why?
|
| Spectrin | 1 | 2006 | 177 | 0.070 |
Why?
|
| Cells, Cultured | 6 | 2010 | 19233 | 0.070 |
Why?
|
| Cats | 2 | 2004 | 1000 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2007 | 528 | 0.070 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2005 | 135 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 2016 | 3854 | 0.060 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 2004 | 87 | 0.060 |
Why?
|
| Dinucleoside Phosphates | 1 | 2004 | 74 | 0.060 |
Why?
|
| Cues | 2 | 2010 | 875 | 0.060 |
Why?
|
| Ibuprofen | 1 | 2006 | 236 | 0.060 |
Why?
|
| Autonomic Pathways | 1 | 2004 | 30 | 0.060 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2006 | 214 | 0.060 |
Why?
|
| Magnesium Sulfate | 1 | 2004 | 68 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2015 | 1188 | 0.060 |
Why?
|
| Choice Behavior | 1 | 2010 | 802 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 529 | 0.060 |
Why?
|
| Physical Stimulation | 1 | 2005 | 525 | 0.060 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2010 | 1433 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 919 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2004 | 708 | 0.060 |
Why?
|
| Decision Making | 1 | 2017 | 3888 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2006 | 554 | 0.050 |
Why?
|
| Trypsinogen | 1 | 2002 | 86 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 1771 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2004 | 1386 | 0.050 |
Why?
|
| Spinal Canal | 1 | 2022 | 39 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 40559 | 0.050 |
Why?
|
| Trypsin | 1 | 2002 | 511 | 0.050 |
Why?
|
| Lung | 1 | 2020 | 9857 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2006 | 844 | 0.050 |
Why?
|
| Bioprosthesis | 1 | 2005 | 597 | 0.050 |
Why?
|
| Calcium | 4 | 2010 | 5755 | 0.050 |
Why?
|
| Caspases | 1 | 2004 | 928 | 0.050 |
Why?
|
| Influenza Vaccines | 1 | 2008 | 738 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2004 | 772 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2009 | 1917 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 544 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 5534 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 15078 | 0.050 |
Why?
|
| Pseudarthrosis | 1 | 2020 | 59 | 0.050 |
Why?
|
| Hydrogels | 1 | 2006 | 724 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 8861 | 0.050 |
Why?
|
| Biopsy | 2 | 2015 | 6755 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 14723 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 791 | 0.050 |
Why?
|
| Debridement | 1 | 2022 | 492 | 0.040 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2003 | 475 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2005 | 788 | 0.040 |
Why?
|
| Glucocorticoids | 2 | 2020 | 2108 | 0.040 |
Why?
|
| Attention | 1 | 2010 | 2397 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2022 | 12207 | 0.040 |
Why?
|
| Atherosclerosis | 1 | 2015 | 3444 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2015 | 4253 | 0.040 |
Why?
|
| Antibodies, Bacterial | 2 | 2016 | 1470 | 0.040 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 39052 | 0.040 |
Why?
|
| Abscess | 1 | 2022 | 607 | 0.040 |
Why?
|
| Directed Tissue Donation | 1 | 2018 | 19 | 0.040 |
Why?
|
| Neuroglia | 1 | 2003 | 928 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 1837 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2023 | 967 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2020 | 925 | 0.040 |
Why?
|
| Extremities | 1 | 2023 | 866 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2006 | 1736 | 0.040 |
Why?
|
| Actinobacillus Infections | 1 | 2016 | 16 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2749 | 0.040 |
Why?
|
| Health Records, Personal | 1 | 2018 | 124 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2006 | 1862 | 0.030 |
Why?
|
| Synapses | 1 | 2006 | 1728 | 0.030 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 567 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2004 | 3207 | 0.030 |
Why?
|
| Skeletal Muscle Myosins | 1 | 2015 | 2 | 0.030 |
Why?
|
| DNA Primers | 2 | 2012 | 2891 | 0.030 |
Why?
|
| Advance Directives | 1 | 2018 | 246 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2005 | 13035 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 35425 | 0.030 |
Why?
|
| Motor Activity | 1 | 2006 | 2715 | 0.030 |
Why?
|
| Hippocampus | 2 | 2006 | 3675 | 0.030 |
Why?
|
| Pancreatitis | 1 | 2002 | 1092 | 0.030 |
Why?
|
| Myoglobin | 1 | 2015 | 160 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 1745 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2022 | 1299 | 0.030 |
Why?
|
| Antibodies | 1 | 2002 | 2460 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 862 | 0.030 |
Why?
|
| Toes | 1 | 2015 | 206 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2023 | 12721 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 414 | 0.030 |
Why?
|
| Uric Acid | 1 | 2019 | 766 | 0.030 |
Why?
|
| Maze Learning | 2 | 2006 | 478 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2023 | 15520 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2013 | 226 | 0.030 |
Why?
|
| Sigma Factor | 1 | 2014 | 175 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 212 | 0.030 |
Why?
|
| Gene Expression | 3 | 2016 | 7798 | 0.030 |
Why?
|
| Acriflavine | 1 | 2012 | 6 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2013 | 719 | 0.030 |
Why?
|
| Genotype | 1 | 2007 | 12952 | 0.030 |
Why?
|
| Spinal Diseases | 1 | 2017 | 538 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2019 | 1828 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2012 | 356 | 0.030 |
Why?
|
| Embryo Transfer | 1 | 2015 | 510 | 0.030 |
Why?
|
| Immunization | 1 | 2016 | 1256 | 0.030 |
Why?
|
| Serotyping | 1 | 2012 | 338 | 0.030 |
Why?
|
| Complementarity Determining Regions | 1 | 2012 | 149 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2015 | 673 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 2019 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 3130 | 0.020 |
Why?
|
| Zebrafish | 1 | 2022 | 2996 | 0.020 |
Why?
|
| Back Pain | 1 | 2015 | 545 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2021 | 53290 | 0.020 |
Why?
|
| Reoperation | 1 | 2020 | 4201 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2015 | 1730 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2576 | 0.020 |
Why?
|
| Prognosis | 2 | 2023 | 29060 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2014 | 691 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2015 | 1767 | 0.020 |
Why?
|
| Xanthenes | 1 | 2009 | 73 | 0.020 |
Why?
|
| Child | 4 | 2020 | 77709 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2010 | 176 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2015 | 818 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2014 | 1525 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17446 | 0.020 |
Why?
|
| Bone Density | 1 | 2022 | 3468 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3265 | 0.020 |
Why?
|
| Reassortant Viruses | 1 | 2008 | 37 | 0.020 |
Why?
|
| Cognition | 1 | 2006 | 6770 | 0.020 |
Why?
|
| Brain | 3 | 2004 | 26388 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2009 | 138 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 4010 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2010 | 595 | 0.020 |
Why?
|
| Virulence | 1 | 2012 | 1333 | 0.020 |
Why?
|
| Temperature | 1 | 2014 | 2204 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 2478 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 3773 | 0.020 |
Why?
|
| Independent Living | 1 | 2012 | 568 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12356 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1312 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7882 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 5895 | 0.020 |
Why?
|
| Escherichia coli Proteins | 1 | 2014 | 1050 | 0.020 |
Why?
|
| Astrocytes | 2 | 2006 | 1273 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9274 | 0.020 |
Why?
|
| Equipment Design | 2 | 2005 | 3582 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1403 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1899 | 0.020 |
Why?
|
| Women's Health | 1 | 2016 | 2034 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7730 | 0.020 |
Why?
|
| Neocortex | 1 | 2010 | 400 | 0.020 |
Why?
|
| Movement Disorders | 1 | 2010 | 446 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 6621 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 2251 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 2012 | 1172 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 5451 | 0.020 |
Why?
|
| Cell Enlargement | 1 | 2005 | 61 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2006 | 387 | 0.020 |
Why?
|
| Base Sequence | 2 | 2009 | 12797 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10400 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 4569 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2009 | 986 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 896 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 1622 | 0.020 |
Why?
|
| Cell Line | 2 | 2009 | 16000 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 13814 | 0.010 |
Why?
|
| Growth Cones | 1 | 2004 | 117 | 0.010 |
Why?
|
| Elasticity | 1 | 2005 | 657 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2018 | 20130 | 0.010 |
Why?
|
| Neutrophils | 2 | 2009 | 3721 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2004 | 249 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2015 | 3690 | 0.010 |
Why?
|
| Incidence | 1 | 2021 | 20952 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 868 | 0.010 |
Why?
|
| Time | 1 | 2004 | 542 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2004 | 311 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
| Body Weight | 1 | 2013 | 4671 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2004 | 580 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 10943 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 758 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2004 | 506 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13286 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 748 | 0.010 |
Why?
|
| Random Allocation | 1 | 2006 | 2428 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8319 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2003 | 318 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2004 | 1147 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2004 | 1799 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2008 | 1900 | 0.010 |
Why?
|
| Granulocytes | 1 | 2002 | 548 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2004 | 635 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10388 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3759 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 4805 | 0.010 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2004 | 584 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2005 | 541 | 0.010 |
Why?
|
| Virus Replication | 1 | 2008 | 2535 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 1856 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1970 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23336 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
| Kidney | 1 | 2015 | 7184 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2716 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12746 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15221 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 8987 | 0.010 |
Why?
|
| Macrophages | 2 | 2003 | 5660 | 0.010 |
Why?
|
| Microglia | 1 | 2006 | 1267 | 0.010 |
Why?
|
| Mutation | 1 | 2002 | 29786 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6366 | 0.010 |
Why?
|
| Amyloidosis | 1 | 2003 | 796 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 2700 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10483 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 41005 | 0.010 |
Why?
|
| Quality of Life | 1 | 2012 | 12802 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 81201 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 9145 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 12073 | 0.000 |
Why?
|
| Age Factors | 1 | 2003 | 18373 | 0.000 |
Why?
|
| Algorithms | 1 | 2006 | 13882 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 13693 | 0.000 |
Why?
|
| Neoplasms | 1 | 2009 | 21696 | 0.000 |
Why?
|